Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

April 28, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Signal describes agents that block transcription factor activation

April 24, 1997

Phase III results for TS-110 in osteoarthritis

April 23, 1997

Caspase-1 involved in the regulation of multiple cytokines

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

New MMP inhibitor disclosed by Agouron

April 18, 1997

New COX-2 inhibitor from Searle

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...